Author： El-Sakka Ahmed I
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.13, 2005-10, pp. : 2223-2230
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
3 -Adrenoceptors in the cardiovascular system
By Gauthier C. Langin D. Balligand J.-L.
Trends in Pharmacological Sciences, Vol. 21, Iss. 11, 2000-11 ,pp. :
Access to resources
Recommend
Toxins that affect the cardiovascular system
By Thanacoody HK Ruben Waring W Stephen
Clinical Medicine, Vol. 8, Iss. 1, 2008-02 ,pp. :
Tachykinins and the Cardiovascular System
Current Drug Targets, Vol. 7, Iss. 8, 2006-08 ,pp. :
Sleep apnoea syndromes and the cardiovascular system
Clinical Medicine, Vol. 11, Iss. 3, 2011-06 ,pp. :
Vasopressin and Oxytocin in Control of the Cardiovascular System
Current Neuropharmacology, Vol. 11, Iss. 2, 2013-03 ,pp. :